NCT07356869

Brief Summary

This study aims to compare the efficacy of probiotic-based mouthwashes versus ethyl lauroyl arginate-containing mouthwashes in reducing Streptococcus mutans count, dental plaque accumulation, and salivary pH among a group of Egyptian schoolchildren.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Aug 2025Sep 2026

Study Start

First participant enrolled

August 15, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 13, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 21, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

January 21, 2026

Status Verified

January 1, 2026

Enrollment Period

1 year

First QC Date

January 13, 2026

Last Update Submit

January 13, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • S. mutans count

    S. mutans count will be measured at baseline (0 day) and post-intervention (28 days).

    28 days post-intervention

Secondary Outcomes (2)

  • Plaque index score

    28 days post-intervention

  • Salivary pH

    28 days post-intervention

Study Arms (3)

Group A

EXPERIMENTAL

Patients will be receive probiotic mouthwash and instructed to rinse 5ml twice daily for 30 seconds for 28 days.

Other: Probiotic mouthwash

Group B

EXPERIMENTAL

Patients will be treated with ethyl lauroyl arginate-containing mouthwash and instructed to rinse 5ml twice daily for 30 seconds for 28 days.

Other: Ethyl lauroyl arginate mouthwash

Group C

ACTIVE COMPARATOR

Patients will receive professional prophylaxis (scaling + polishing) at baseline and will use only regular toothpaste twice daily, with no adjunctive mouthwashes over 28 days.

Other: Professional prophylaxis (scaling + polishing)

Interventions

Patients will be receive probiotic mouthwash and instructed to rinse 5ml twice daily for 30 seconds for 28 days.

Group A

Patients will be treated with ethyl lauroyl arginate mouthwash and instructed to rinse 5ml twice daily for 30 seconds for 28 days.

Group B

Patients will receive professional prophylaxis (scaling + polishing) at baseline and will use only regular toothpaste twice daily, with no adjunctive mouthwashes over 28 days.

Group C

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Healthy Egyptian schoolchildren aged 6-12 years.
  • Good general health.
  • Mild to moderate dental plaque accumulation.
  • Parental/caregiver willingness to provide consent

You may not qualify if:

  • Antibiotic or antimicrobial use within the last month.
  • Allergies to the mouthwash components.
  • Systemic diseases affecting oral health.
  • Orthodontic appliances or extensive dental restorations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al-Azhar University (Faculty of Dentistry)

Cairo, 11651, Egypt

RECRUITING

MeSH Terms

Conditions

Dental Plaque

Interventions

Tooth Exfoliation

Condition Hierarchy (Ancestors)

Dental DepositsTooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Dental Physiological PhenomenaDigestive System and Oral Physiological Phenomena

Central Study Contacts

Mohamed O Abdelrazik, MBBCH

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
B.D.S, Faculty of Dental Medicine (Cairo-Boys), Al-Azhar University

Study Record Dates

First Submitted

January 13, 2026

First Posted

January 21, 2026

Study Start

August 15, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

January 21, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Shared Documents
STUDY PROTOCOL
Time Frame
After the end of study for one year.
Access Criteria
The data will be available upon a reasonable request from the corresponding author.

Locations